Expected Impact of Biosimilars on the Pharmaceutical Companies

Stay connected! Follow us on X network (Twitter):

Share this content! On (X network) By

Expected Impact of Biosimilars on the Pharmaceutical Companies Publisher Pubmed

Golshani S^{1, 2} ; Faramarzi MA¹

Show Affiliations

1. Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
2. Department of Drug and Food Control, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Source: Iranian Journal of Medical Sciences Published:2021

[No abstract available]

Style	Citing Format
MLA	Golshani S, Faramarzi MA. "Expected Impact of Biosimilars on the Pharmaceutical Companies." Iranian Journal of Medical Sciences, vol. 46, no. 5, 2021, pp. 399-401.
APA	Golshani S, Faramarzi MA (2021). Expected Impact of Biosimilars on the Pharmaceutical Companies. Iranian Journal of Medical Sciences, 46(5), 399-401.
Chicago	Golshani S, Faramarzi MA. "Expected Impact of Biosimilars on the Pharmaceutical Companies." Iranian Journal of Medical Sciences 46, no. 5 (2021): 399-401.
Harvard	Golshani S, Faramarzi MA (2021) 'Expected Impact of Biosimilars on the Pharmaceutical Companies', Iranian Journal of Medical Sciences, 46(5), pp. 399-401.
Vancouver	Golshani S, Faramarzi MA. Expected Impact of Biosimilars on the Pharmaceutical Companies. Iranian Journal of Medical Sciences. 2021;46(5):399-401.
BibTex	@article{ author = {Golshani S and Faramarzi MA}, title = {Expected Impact of Biosimilars on the Pharmaceutical Companies}, journal = {Iranian Journal of Medical Sciences}, volume = {46}, number = {5}, pages = {399-401}, year = {2021} }
RIS	TY - JOUR AU - Golshani S AU - Faramarzi MA TI - Expected Impact of Biosimilars on the Pharmaceutical Companies JO - Iranian Journal of Medical Sciences VL - 46 IS - 5 SP - 399 EP - 401 PY - 2021 ER -